Nottingham Galway - National University of Ireland, Galway
Nottingham Galway - National University of Ireland, Galway
Nottingham Galway - National University of Ireland, Galway
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Session 7: TREATMENT SELECTION<br />
Chaired by: Dr Cecily Quinn, Pr<strong>of</strong>essor Carsten Rose<br />
Panel: Mr Karl Sweeney, Dr Sinead Walsh, Ms Mairead Lyons<br />
2.00 Targeted Radiotherapy: Who / How<br />
Dr Joe Martin<br />
Consultant Radiologist, <strong>Galway</strong> <strong>University</strong> Hospital, <strong>Galway</strong>, <strong>Ireland</strong><br />
2.15 Experience with PB Radiation<br />
Pr<strong>of</strong>essor Frank Sullivan<br />
Pr<strong>of</strong>essor <strong>of</strong> Radiation Oncology, NUI <strong>Galway</strong>, <strong>Ireland</strong><br />
2.30 Selection for Hormone Responsiveness - Which Patients can Avoid Chemotherapy?<br />
Pr<strong>of</strong>essor Nigel Bundred<br />
Pr<strong>of</strong>essor in Surgical Oncology, <strong>University</strong> Hospital <strong>of</strong> South Manchester,<br />
Wythenshawe, UK<br />
2.45 Sentinel Node Biopsy and Neoadjuvant Therapy<br />
Mr Malcolm Kell<br />
Consultant Surgeon, BreastCheck, Dublin, <strong>Ireland</strong><br />
3.00 Screen Detected Lesions: Implications for Intervention<br />
Dr Margaret Sheehan<br />
Consultant Pathologist, BreastCheck West, <strong>Galway</strong> <strong>University</strong> Hospital,<br />
<strong>Galway</strong>, <strong>Ireland</strong><br />
3.15 Discussion<br />
3.30 C<strong>of</strong>fee<br />
Session 8: PROGNOSIS<br />
Chaired by: Pr<strong>of</strong>essor Paul Redmond, Pr<strong>of</strong>essor Mike Dixon<br />
Panel: Dr Paul Donnellan, Dr Cecily Quinn, Pr<strong>of</strong>essor Carsten Rose<br />
4.00 New Methods <strong>of</strong> Predicting Outcome using Adjuvant Online for Europe<br />
Pr<strong>of</strong>essor Gordon Wishart<br />
Consultant Breast & Endocrine Surgeon, Cambridge Breast Unit, Addenbrooke's<br />
Hospital, Cambridge, UK<br />
4.15 Twenty Years Experience with NPI<br />
Pr<strong>of</strong>essor Roger Blamey<br />
Emeritus Pr<strong>of</strong>essor (Surgery) and Consultant Surgeon, <strong>Nottingham</strong> <strong>University</strong><br />
Hospitals NHS Trust, UK<br />
4.30 Correlation <strong>of</strong> (International) BrCa long-term Mortality Trends with the<br />
Access to Cancer Care<br />
Pr<strong>of</strong>essor Joseph Ragaz<br />
Pr<strong>of</strong>essor <strong>of</strong> Medicine & Oncology, McGill <strong>University</strong>, Canada<br />
4.45 Outcome <strong>of</strong> Oncopool Study<br />
Pr<strong>of</strong>essor Michael Kerin<br />
Pr<strong>of</strong>essor <strong>of</strong> Surgery, NUI <strong>Galway</strong>, <strong>Galway</strong>, <strong>Ireland</strong><br />
5.00 Close <strong>of</strong> Meeting<br />
9